baber/WOPTO huggingface dataset:
Patent NZ-568998-A (NZ)
Title: Nasal and oral cannula having three or more separate flow paths and method of producing same
Inventor: CURTI JAMES N
IPC: A61G10/00
Filed: 2006-11-10
Abstract: Disclosed is a cannula having at least three completely separate flow paths. The cannula includes a nasal main body having first and second main flow chambers respectively communicating with first and second main body ports. The first and the second main flow chambers are separated from one another by a nasal septum. The cannula includes a mouth main body located adjacent the nasal main body and having at least a third main flow chamber therein communicating with at least a third port, and the third main flow chamber being completely separate from both the first and the second main flow chambers. The cannula also includes a first nare having a first nasal port and a first nasal flow chamber communicating with the first main flow chamber; a second nare having a second nasal port and a second nasal flow chamber communicating with the second main flow chamber and a first mouthpiece having a first mouth port and a first mouthpiece flow chamber communicating with the third main flow chamber. A first flow path comprises the first main body port, the first main flow chamber, the first nasal flow chamber and the first nasal port. A second flow path comprises the second main body port, the second main flow chamber, the second nasal flow chamber and the second nasal port. A third flow path comprises the third port, the third main flow chamber, the first mouthpiece flow chamber and the first mouth port.
Patent NZ-571083-A (NZ)
Title: Lactic acid bacteria providing improved texture of fermented dairy products
Inventor: JANZEN THOMAS
IPC: A23C9/123
Filed: 2007-02-20
Abstract: Provided is a lactic acid Streptococcus thermophilus (ST) bacterium with the registration number DSM 17876 or a mutant strain thereof, wherein the mutant strain is obtained by using the deposited strain as starting material, and wherein the mutant has retained or further improved the texturing properties of DSM 17876. Also provided is a method of manufacturing a food or feed product by fermenting using the bacterium and food or feed products produced by the method.
Patent NZ-581717-A (NZ)
Title: Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
Inventor: BUFFIERE FREDERIC
IPC: G01N33/569
Filed: 2008-06-06
Abstract: Provided is an in vitro method for identifying a plurality of antigenic molecules carried by the erythrocytes of an individual, and/or for identifying a plurality of antibodies against antigenic molecules carried by erythrocytes, in a biological sample, said antigenic molecules carried by the erythrocytes consisting of molecules of the HLA system, or of phosphatidylserine, said method comprising a) identifying a plurality of antigenic molecules carried by the erythrocytes of an individual, by (i) bringing said sample containing erythrocytes into contact, in a single test receptacle, or in several separate test receptacles, with groups of distinguishable beads, each group of distinguishable beads carrying a given antibody, specific for an antigenic molecule carried by erythrocytes, which differs from one group of beads to the other, under conditions which allow the erythrocytes to bind to the antibodies, without agglutination, said erythrocytes being labelled before or after they have been brought into contact with said groups of beads, (ii) eliminating the erythrocytes which have not bound to said antibodies, and (iii) identifying the group of beads having bound the labelled erythrocytes, thereby allowing the identification of the antigens carried by the erythrocytes detected; and/or b) identifying a plurality of antibodies against antigenic molecules carried by erythrocytes in a biological sample, by (iv) bringing said sample into contact, in a single test receptacle, or in several separate test receptacles, with groups of distinguishable beads, each group of distinguishable beads carrying (1) erythrocytes or (2) erythrocyte membrane fragments, of known phenotype which differs from one group of beads to the other, under conditions which allow the antibodies or the activated serum complement fractions present in the sample to bind to the erythrocytes or to the erythrocyte membrane fragments without agglutination, (v) eliminating the antibodies or activated serum complement fractions which have not bound to said erythrocytes or to said erythrocyte membrane fragments, (vi) labelling the bound antibodies and/or the bound activated serum complement fractions, and (vii) identifying the group of beads having bound the labelled antibodies or the labelled activated serum complement fractions, thereby allowing the identification of the antibodies against antigenic molecules carried by the erythrocytes, that are present.
Patent NZ-589574-A (NZ)
Title: Salts and polymorphs of a tetracycline compound
Inventor: CVETOVICH RAYMOND
IPC: A01N37/18
Filed: 2009-05-26
Abstract: Disclosed is a tosylate salt of an aminoalkyl tetracycline compound (4S,4AS,5AR,12AS)-4-7-Bis(dimethylamino)-9 { [(2,2-dimethylpropyl)amino]methyl} -3,10,12,12A-tetrahydroxy-1,11-dioxo-1,4,4A,5,5A,6,11,12A-octahydrotetracene-2-carboxamide (9-(2,2-dimethyl-propyl-aminomethyl)-minocycline) and a crystalline form of said tosylate salt. A polymorph of the crystalline form of this compound having an X-ray powder diffraction pattern with preaks at approximately 8.06, 13.02 and 18.83 2 degrees theta, is also disclosed. Also disclosed is a method for preparing the above mentioned crystalline tosylate salt.
Patent NZ-593710-A (NZ)
Title: Flavor enhancing agent and flavoring composition
Inventor: NONAKA YUJI
IPC: A23L27/10
Filed: 2009-12-25
Abstract: Disclosed are packaged beverages produced via a process including a sterilization treatment, which comprise 1-50 wt% of a fruit juice and a polymerized catechin derived from a tea leaf extract. Also disclosed are packaged beverages produced via a process including a sterilization treatment, which comprise a fruit or plant flavoring and a polymerized catechin derived from a tea leaf extract wherein the beverage has a Brix value of 1.0 or less. The polymerised catechin may preferably be an epigallocatechin gallate dimer.
Patent NZ-610939-A (NZ)
Title: Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]- benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with bicyclic benzene derivatives
Inventor: MEERPOEL LIEVEN
IPC: C07D487/04
Filed: 2011-12-19
Abstract: The disclosure relates to antifungal 5,6-dihydro-4H-pyrrolo-[1,2-a][1,4]benzodiazepines and 6H-pyrrolo-[1,2-a][1,4]benzodiazepines substituted with bicyclic benzene derivatives of formula (I) wherein the variables R1, R2, R3, R4, R5, R6 and R7 have the meaning defined in the specification. These compounds are active mainly against dermatophytes and systemic fungal infections. Also disclosed are processes for preparing these compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament for treating fungal infections.
Patent NZ-611063-A (NZ)
Title: Controlled evacuation ostomy appliance
Inventor: TSAI MINGLIANG LAWRENCE
IPC: A61F5/443
Filed: 2011-10-27
Abstract: A controlled discharge ostomy appliance (10) comprising: a stomal aperture (18); a non-entrant stoma seal (22); an inner coupling member (24) coupled to support the stoma seal for retaining the stoma seal in an operative position with respect to the stomal aperture; and an outer coupling member (20) around the inner coupling member for supporting the appliance. The operative position is selected such that, in use, a seal pressure applied between the stoma seal and the stoma when the stoma is quiescent is not more than about 1 psi.
Patent NZ-619297-A (NZ)
Title: Intraocular drug delivery systems
Inventor: BLANDA WENDY M
IPC: A61K47/48
Filed: 2007-11-09
Abstract: Disclosed is a biocompatible, injectable intraocular drug delivery system comprising: (a) a plurality of microspheres with an average diameter between about 8 microns and about 14 microns, and (b) an aqueous vehicle for the microspheres, wherein the microspheres consist essentially of: (1) aa therapeutic agent which is a prostaglandin or bimatoprost, latanoprost or 7-{ 2-[5-(3-fluoro-4-methyl-thiophen-2-yl)-3-methoxy-pent-1-enyl]-3,5-dihydroxycyclopentyl} -hept-5-enoic acid ethyl amide, and; (2) one or more biodegradable polymers, all of which biodegradable polymers are polylactic acid (PLA) polymers, and; wherein the drug delivery system has a viscosity which permits the drug delivery system to be injected into an intraocular location through a 20 to 30 gauge syringe needle.
Patent NZ-620020-A (NZ)
Title: Heterocyclic compounds and uses thereof
Inventor: CHAN KATRINA
IPC: A61K31/54
Filed: 2010-08-17
Abstract: Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, and the use thereof in the treatment of a condition associated with phosphatidyl inositol-3 kinase (PI3 kinase), specifically wherein the treatment comprises inhibiting said kinase. In one embodiment the treatment is the treatment of non-small cell lung cancer or small cell lung cancer.
Patent NZ-621596-A (NZ)
Title: Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
Inventor: FORSHAG MARK
IPC: A61P11/00
Filed: 2012-11-22
Abstract: Discloses the use of Alpha1-proteinase inhibitor (A1PI) in the manufacture of a medicament for diminishing progression of one or more of a first set of symptoms associated with a pulmonary disease or disorder from worsening and/or increasing in severity in a subject in need thereof comprising: identifying the subject as in need of diminishing progression of said one or more of the first set of symptoms associated with a pulmonary disease or disorder from worsening and/or increasing in severity by identifying one or more of a second set of symptoms predictive of the pulmonary disease or disorder, wherein the second set of symptoms comprises: i) an increased cough; ii) a change in sputum; iii) decreased appetite and/or decreased weight; iv) a change in respiratory examination and/or respiratory rate; wherein said medicament comprises an effective amount of (A1PI) and is to be administered to said identified subject via inhalation prior to onset of said one or more of the first set of symptoms, wherein the first set of symptoms comprises: (a) shortness of breath; (b) fatigue; (c) a chronic cough; (d) a reduction in forced expiratory volume (FEV1); and (e) decline in expiratory gas markers of respiratory inflammation; and wherein the administration is to be carried out at least daily for a plurality of months.
Patent NZ-625850-A (NZ)
Title: Methods and compositions for treatment of pulmonary fibrotic disorders
Inventor: SPANGLER RHYANNON
IPC: A61K39/00
Filed: 2010-08-20
Abstract: Disclosed is a method for monitoring response to a treatment of at least one symptom of a pulmonary fibrotic disorder, the method comprising determining a level of LOXL2 in a sample of pulmonary tissue from a subject, wherein a decreased level of LOXL2 in the sample from the subject, compared to a control sample, indicates an amelioration of the at least one symptom of the pulmonary fibrotic disorder in the subject, wherein the symptom is an increase in pulmonary leukocyte number in the subject.
Patent NZ-708124-A (NZ)
Title: End lap system for roof cladding sheets
Inventor: KRALIC JOHN FRANK
IPC: E04D13/16
Filed: 2013-11-15
Abstract: A clip (61) for holding together an upper roof cladding sheet (29a) and a lower roof cladding sheet (29b) in an end to end, i.e. end lap, relationship on a roof. The clip is formed to fit over and lock onto a rib (31) of the lower cladding sheet and to retain the upper sheet on the clip. An elongate weather strip (57) is formed from a compressible material and includes a pan section (81) that can fill a gap between overlapping pans of the cladding sheets. The pan section includes an upper surface having a series of troughs (87) and ridges (89) along the length of the pan section that has the result of providing the pan section with a variable height along the length of the pan section. The ridges of the pan section compress when the upper roof cladding sheet is positioned on and engaged with the lower cladding sheet in an overlapping relationship with the pan section filling the gap between the cladding sheets.
Patent NZ-739404-A (NZ)
Title: Electronic vapour provision system
Inventor: OTIABA KENNY
IPC: A24F40/50
Filed: 2016-08-24
Abstract: Most e-cigarettes are powered by re-chargeable lithium ion batteries. Conventional lithium ion batteries are based on a cathode made from lithium cobalt oxide and produce a voltage output that tends to decline as they discharge. The change in power supplied by the battery to a heater, from being fully charged to being nearly discharged, can therefore significantly impact the amount of liquid vaporised, and hence inhaled by a user. The present disclosure relates to a control unit for an electronic vapour system. The control unit for an electronic vapour provision system includes a battery for providing electrical power to a heater which is used to produce vapour and a circuit board for controlling the electronic vapour provision system. The control unit also includes a sensor unit to detect an inhalation on mouthpiece. A tip end of the control unit may be provided with an electrical contact, the electrical contact being mounted on a coil spring. The battery is a lithium iron phosphate battery. The battery provides an output voltage which remains at an approximately constant voltage level as the battery is discharged. In an embodiment, the output voltage of the battery when 80% discharged by successive puffs of the electronic vapour provision system is no more than 0.25V below the output voltage of the battery when fully charged, said battery having a rated capacity in the range 250-600 mA hours to support at least 100 puffs of the electronic vapour provision system, each puff drawing a current of at least 2.5A from the battery
Patent NZ-740338-A (NZ)
Title: Compositions and methods for modulating apolipoprotein (a) expression
Inventor: SWAYZE ERIC E
IPC: C07K14/775
Filed: 2014-05-01
Abstract: Discloses a compound comprising a modified oligonucleotide and a conjugate group, wherein the modified oligonucleotide consists of 12-30 contiguous nucleobases comprising a portion of at least 8 contiguous nucleosides complementary to an equal length portion of nucleobases of SEQ ID NO: 1, wherein the nucleobase sequence of the modified oligonucleotide complementary to SEQ ID NO: 1; and wherein the conjugate group and sequences are as defined in the complete specification.
Patent NZ-746950-A (NZ)
Title: Heterocyclic gpr119 agonist compounds
Inventor: PATIL RAKESH
IPC: C07D417/14
Filed: 2017-04-05
Abstract: The present invention relates to novel compounds of formula (II), process for preparation of the same and composition comprising these compounds. The compounds are useful in the treatment and prevention of metabolic disorders, including diabetes mellitus (type I and type II).
Patent NZ-752750-A (NZ)
Title: Stable aqueous capsaicin injectable formulations and medical uses thereof
Inventor: OSTOVIC DRAZEN
IPC: C08L91/00
Filed: 2017-11-02
Abstract: The invention provides stable, aqueous capsaicin injectable formulations, a unit dose containing such injectable formulations, medical kits, and methods for using such injectable formulations and unit doses to treat patients suffering from pain, such as osteoarthritic knee pain. The stable, aqueous capsaicin injectable formulations may contain, for example, capsaicin, a solubilizing agent (e.g., a polyethylene glycol ester of a (C15-C25) hydroxyalkanoic acid), an antioxidant, and water.
Patent NZ-755141-A (NZ)
Title: Methods of treating bacterial infections
Inventor: LOUTIT JEFFREY
IPC: A61P31/04
Filed: 2018-01-08
Abstract: Methods of treating or ameliorating urinary tract infection (UTI), including complicated urinary tract infection (cUTI) and acute pyelonephritis (AP), comprising administering a composition comprising a cyclic boronic acid ester vaborbactam in combination with meropenem are disclosed herewith.
Patent NZ-781551-A (NZ)
Title: Device for biostimulating phototherapy
Inventor: GERSTENMEIER JÜRGEN
IPC: A61N5/06
Filed: 2020-04-02
Abstract: The invention relates to a device for biostimulating phototherapy, in particular in conjunction with a therapy appliance. The device comprises at least one first light-emitting unit for directly and/or indirectly applying light of a first wavelength to at least one part of a human or animal body, and a control unit for outputting application routines. The device also comprises a module interface for operatively connecting the control unit to the at least one first light-emitting unit, and a core interface for operative connection to a therapy appliance. The control unit is designed such that it is able to receive data from the therapy apparatus via the core interface and, on the basis of these data, is able to control the output of an application routine via the module interface wherein the data from the therapy apparatus is indicative of parameters of the therapy apparatus and/or parameters of treatment delivered by the therapy apparatus. The invention also relates to: a therapy appliance fitted with the device according to the invention, for physical treatment of a patient using enhanced biostimulating phototherapy; a method for operating a device according to the invention; and a computer program product for executing this method.
Patent PT-100280-A (PT)
Title: Process and installation for the treatment of waste water with a high crude-oil content
IPC: C02F/
Filed: 1992-03-23
Abstract: Process and installation for the treatment of waste water with a high crude-oil content, especially waste water from the ballast of oil tankers, waste water resulting from cleaning the inside of the tanks of petrol tankers, etc., with the aim of promoting its separation and the recovery of the petroleum, which comprises the collection and the storage of the water to be treated, the sedimentation of the water successfully separated, chemical treatment at high temperature with a product which will depend on the type of crude oil, the separation of the water/petroleum and storage of the separated petroleum. The field of use of the present invention is in the area of combating marine pollution by crude petroleum and the recovery of the latter.
Patent RO-82948-A (RO)
Inventor: ANDERSON JOHN E
IPC: F23D14/00
Filed: 1981-04-09
Abstract: The present invention deals with an oxygen aspirator burner (1) and a process for firing a furnace with an oxygen-enriched oxidant gas. The process and apparatus for firing a furnace using oxygen or oxygen-enriched air as the oxidant gas, comprises injection into the furnace of a plurality of oxidant jets (8), through nozzles (4), in a spaced relationship to a fuel jet (9), at a velocity sufficient to cause aspiration of furnace gases into the oxidant jets before the latter mix with the fuel jet, in amounts sufficient to lower flame temperature.
Patent RU-94027301-A (RU)
Inventor: KORZHIK V I
IPC: H04L9/00
Filed: 1994-07-18
Abstract: FIELD: cryptography. SUBSTANCE: method involves generation of confidential circular code keyword by choose of coefficients of symmetric polynomials f(x,x) by means of random number generator, generation of personal user identification keyword by means of substitution of user identifier in polynomials f(x,x), generation of current session keyword by means of substitution of it to personal keyword of respondent identifier. Device provides possibility of keyword distribution which is reliable to given number of disclosing personal user keywords in order to provide their confidential communications. EFFECT: simplified hardware-software design using single standard microprocessor, increased speed for generation of session keywords, decreased probability of faults when personal keyword is output, simplified storage of personal keywords, increased stability to external mechanical and electromagnetic interference. 1 dwg
Patent RU-94030327-A (RU)
Inventor: OMEL CHENKO V V
IPC: G05B23/02
Filed: 1994-08-17
Abstract: FIELD: technical cybernetics. SUBSTANCE: method may be applied for automatic control systems which solve tasks of recognition and estimation of states of complex objects. Method provides composite estimation of tolerant space with multiple dimensions using remote control data. Novel feature of method is integral estimation of fact that objects transits from some class of states to another one. Estimation uses integral criteria that are generalized by set of parameters. The transition is detected by means of way how intersection area of multiple-parameter tolerant space between said classes of transition. This is represented by ordered set of tolerant sub-spaces, each of which correspond to remote-measured parameter and are ordered by error value. Said parameters provide information about object state and are encoded for each class of object states by some color in visible range. Set of all tolerant sub- spaces when object transits from one class of states to another one is marked by special color and is ordered by error value. Method provides possibility to design efficient real-time expert systems for estimation of state of complex objects. EFFECT: increased speed, increased precision of recognition.
Patent RU-94031155-A (RU)
Inventor: RICHARD MEHNSFILD BIMS
IPC: C07C323/58
Filed: 1992-12-23
Abstract: FIELD: organic chemistry, medicine. SUBSTANCE: desired amidine derivatives have formula I where Ris linear or branched C-alkyl group, C--alkenyl group, C-alkynyl group, C-cycloalkyl group or C-cycloalkyl C-alkyl group; Q is alkylene, alkenylene or alkynylene-group with 3-6 atoms being alternatively substituted by one or more C-alkyl groups; group having formula -(CH)X(CH)where p is number 2 or 3, q is integer 1 or 2 and X represents S(O), where x is 0,1 or 2, or O or NRwhere Ris hydrogen or C-alkyl, or group having formula -(CH)A)CHwhere r is 0,1 or 2, S is 0,1 or 2 and A represents 3-6 membered carbocycle or heterocycle ring which may be alternatively substituted by one or more suitable substituents (e.g. C-alkyl, C-alkoxy, hydroxy, halide, nitro, cyan, trifluoro-C-alkyl, amino, C-alkylamino or di- -C-alkylamino). EFFECT: produces novel compounds.
Patent RU-94032691-A (RU)
Inventor: SMIRNOV V I
IPC: A61F5/00
Filed: 1994-09-08
Abstract: FIELD: medical equipment, audible warning on a change of human body attitude. SUBSTANCE: all elements in the offered device are arranged on a printed- circuit board in the same casing, which is suspended by a thread from the upper part of the breast bone or attached to it by some other means; the device is furnished with an acoustic radiator warming the patient on an improper attitude, the interrupter represents a transmitter consisting of two contacts closed by a flat spring under the action of gravity of a weight with adjustment of the moment of contacts closing and setting of the angle of inclination of instrument response relative to the vertical by means of an adjusting screw driven in threaded hole on the printed-circuit board up to the stop against the flat spring. EFFECT: simplified system of attachment to the patient, miniaturized design, simplified adjustment, audible warming of patient on improper attitude. 1 cl, 2 dwg
Patent RU-94036756-A (RU)
Title: Method of producing isoflavone-enriched vegetable protein isolate
Inventor: DZHEROM L SHEN
IPC: A23L11/00
Filed: 1994-10-10
Abstract: FIELD: production of vegetable oils. SUBSTANCE: isoflavone- containing vegetable protein isolate is obtained when controlling the weight proportion of a raw material to an extracting solution, and avoiding (or minimizing) the step of washing off the acid- precipitated protein courted sludge. EFFECT: elevated isoflavone content.